The neurobiology of attention-deficit/hyperactivity disorder

Biol Psychiatry. 2007 Jun 15;61(12):1317-9. doi: 10.1016/j.biopsych.2007.04.009.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic Uptake Inhibitors / therapeutic use
  • Atomoxetine Hydrochloride
  • Attention Deficit Disorder with Hyperactivity / drug therapy
  • Attention Deficit Disorder with Hyperactivity / epidemiology
  • Attention Deficit Disorder with Hyperactivity / physiopathology*
  • Brain / physiopathology*
  • Central Nervous System Stimulants / therapeutic use
  • Cerebellum / physiopathology
  • Child
  • Corpus Striatum / physiopathology
  • Disruptive, Impulse Control, and Conduct Disorders / epidemiology
  • Disruptive, Impulse Control, and Conduct Disorders / prevention & control
  • Dopamine / physiology
  • Frontal Lobe / physiopathology
  • Humans
  • Methylphenidate / therapeutic use
  • Nerve Net / physiopathology
  • Norepinephrine / physiology
  • Propylamines / therapeutic use
  • Synaptic Transmission / physiology

Substances

  • Adrenergic Uptake Inhibitors
  • Central Nervous System Stimulants
  • Propylamines
  • Methylphenidate
  • Atomoxetine Hydrochloride
  • Dopamine
  • Norepinephrine